Last updated: April 23, 2024
Sponsor: Amsterdam UMC, location VUmc
Overall Status: Active - Recruiting
Phase
N/A
Condition
Infertility
Treatment
ExEm Foam
Oil-based contrast
Clinical Study ID
NCT05882188
NL83352.018.22
Ages 18-42 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Infertile women or women with oligo-or anovulation
- Indication for tubal patency testing during the fertility work-up
- Sufficient understanding of the Dutch or English language
- Signed informed consent
Exclusion
Exclusion Criteria:
- Severe male factor with a total motile sperm count <3x106ml (pre-washed)
- Known contrast (iodine) allergy
- Women who have had a gynecologic procedure within the last 30 days
- Women with known or suspected reproductive tract neoplasia
Study Design
Total Participants: 1102
Treatment Group(s): 2
Primary Treatment: ExEm Foam
Phase:
Study Start date:
September 22, 2023
Estimated Completion Date:
June 01, 2027
Study Description
Connect with a study center
AmsterdamUMC
Amsterdam,
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.